Medical Weight Loss Designed for Long-Term Success At Chronos Body Health & Wellness, weve helped over 10,000 patients safely lose weight with physician-supervised GLP-1 programs using medications like Ozempic, Wegovy, Mounjaro, Zepbound, and compounded alternatives when appropriate
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes
VarElect: the phenotype-based variation prioritizer of the GeneCards suite
Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors
Studies suggest that certain types of foods can stimulate the release of GLP-1 and other appetite-regulating hormones
Neither cagrilintide nor retatrutide is FDA approved as of early 2026